These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21684021)

  • 1. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
    Zhuo JM; Wang H; Praticò D
    Trends Pharmacol Sci; 2011 Sep; 32(9):562-71. PubMed ID: 21684021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.
    Tawfik A; Samra YA; Elsherbiny NM; Al-Shabrawey M
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32751132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
    Li YL; Hou Y; Niu C; Yu LX; Cheng YY; Hong Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):116-8, 127. PubMed ID: 23833960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia and Alzheimer's disease: A systematic review.
    Van Dam F; Van Gool WA
    Arch Gerontol Geriatr; 2009; 48(3):425-30. PubMed ID: 18479766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model.
    Verma N; Gupta JK; Varshney KK; Srivastava R
    Drug Metab Lett; 2021; 14(3):219-231. PubMed ID: 34886786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.
    Sharma M; Tiwari M; Tiwari RK
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):287-96. PubMed ID: 26036286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Induced Hyperhomocysteinemia with Alzheimer's Disease-Like Neurodegeneration in Rat Cortical Neurons After Global Ischemia-Reperfusion Injury.
    Kovalska M; Tothova B; Kovalska L; Tatarkova Z; Kalenska D; Tomascova A; Adamkov M; Lehotsky J
    Neurochem Res; 2018 Sep; 43(9):1766-1778. PubMed ID: 30003389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.
    Di Meco A; Li JG; Praticò D
    J Alzheimers Dis; 2018; 62(3):1337-1344. PubMed ID: 29254095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease.
    Zhuo JM; Portugal GS; Kruger WD; Wang H; Gould TJ; Pratico D
    Curr Alzheimer Res; 2010 Mar; 7(2):140-9. PubMed ID: 19939226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine Levels are Associated with Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients.
    Hu Y; Xu Y; Wang G
    Metab Syndr Relat Disord; 2019; 17(6):323-327. PubMed ID: 31045466
    [No Abstract]   [Full Text] [Related]  

  • 11. Homocysteine and Alzheimer's disease.
    Morris MS
    Lancet Neurol; 2003 Jul; 2(7):425-8. PubMed ID: 12849121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of MTRR A66G polymorphism and promoter methylation with ischemic stroke in patients with hyperhomocysteinemia.
    Li D; Zhao Q; Zhang C; Huang X; Godfrey O; Zhang W
    J Gene Med; 2020 May; 22(5):e3170. PubMed ID: 32034842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Link between Exercise and Homocysteine in the Alzheimer's Disease: A Bioinformatic Network Model.
    Leão LL; Felício LFF; Engedal K; Tangen GG; Kristiansen KM; Santos SHS; de Paula AMB; Monteiro-Junior RS
    CNS Neurol Disord Drug Targets; 2021; 20(9):814-821. PubMed ID: 34852739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia decreases bone blood flow.
    Tyagi N; Vacek TP; Fleming JT; Vacek JC; Tyagi SC
    Vasc Health Risk Manag; 2011 Jan; 7():31-5. PubMed ID: 21339911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: a biomarker in neurodegenerative diseases.
    Herrmann W; Obeid R
    Clin Chem Lab Med; 2011 Mar; 49(3):435-41. PubMed ID: 21388339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction.
    Anniwaer J; Liu MZ; Xue KD; Maimaiti A; Xiamixiding A
    Int J Neurosci; 2019 Jul; 129(7):654-659. PubMed ID: 30215548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes.
    Weekman EM; Johnson SN; Rogers CB; Sudduth TL; Xie K; Qiao Q; Fardo DW; Bottiglieri T; Wilcock DM
    J Neuroinflammation; 2023 Sep; 20(1):199. PubMed ID: 37658433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension.
    Zhang Y; Wang G; Liu J; Xu Y
    Clin Exp Hypertens; 2018; 40(1):28-31. PubMed ID: 29172743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between homocysteine levels and cognitive profile in Alzheimer's Disease.
    Luzzi S; Papiri G; Viticchi G; Baldinelli S; Fiori C; Silvestrini M; Toraldo A
    J Clin Neurosci; 2021 Dec; 94():250-256. PubMed ID: 34863447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRP1 regulates HMGB1 in vascular endothelial cells under high homocysteine condition.
    Ma Y; Zhang Z; Chen R; Shi R; Zeng P; Chen R; Leng Y; Chen AF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1039-H1046. PubMed ID: 30767669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.